Corinne Charlier

Corinne Charlier

Auto-generated profile, based on publicly available information

Corinne Charlier

Laboratory of Clinical, Forensic and Environmental Toxicology, CHU of Liege, B35, 4000 Liege, Belgium; Center for Interdisciplinary Research on Medicines (CIRM), University of Liege (ULg), CHU (B35), 4000 Liege, Belgium

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
PJPincemail Joël
Pincemail Joël
ECEtienne Cavalier
Etienne Cavalier
CCCorinne Charlier
Corinne Charlier
JCJean-Paul Cheramy–Bien
Jean-Paul Cheramy–Bien
EBEric Brevers
Eric Brevers
ARAnne-Françoise Rousseau
Anne-Françoise Rousseau
Background: A key role of oxidative stress has been highlighted in the pathogenesis of COVID-19. However, little has been said about oxidative stress status (OSS) of COVID-19 patients hospitalized in intensive care unit (ICU). Material and Methods: Biomarkers of the systemic OSS included antioxidants (9 assays), trace elements (3 assays), inflammation markers (4 assays) and oxidative damage to lipids (3 assays). Results: Blood samples were drawn after 9 (7–11) and 41 (39–43) days of ICU stay, respectively in 3 and 6 patients. Vitamin C, thiol proteins, reduced glutathione, γ-tocopherol, β-carotene and PAOT® score were significantly decreased compared to laboratory reference values. Selenium concentration was at the limit of the lower reference value. By contrast, the copper/zinc ratio (as a source of oxidative stress) was higher than reference values in 55% of patients while copper was significantly correlated with lipid peroxides (r = 0.95, p < 0.001). Inflammatory biomarkers (C-reactive protein and myeloperoxidase) were significantly increased when compared to normals. Conclusions: The systemic OSS was strongly altered in critically ill COVID-19 patients as evidenced by increased lipid peroxidation but also by deficits in some antioxidants (vitamin C, glutathione, thiol proteins) and trace elements (selenium).

1 December 2014 in Toxicology Letters
Verified
Journal Article
Closed access
LDLucas Dewalque
Lucas Dewalque
CCCorinne Charlier
Corinne Charlier
CPCatherine Pirard
Catherine Pirard


1 December 2003 in Therapeutic Drug Monitoring
Verified
Journal Article
Closed access
CCCorinne Charlier
Corinne Charlier
FBFranck Broly
Franck Broly
MLMichel Lhermitte
Michel Lhermitte
EPEmmanuel Pinto
Emmanuel Pinto
MAMarc Ansseau
Marc Ansseau
GPGuy Plomteux
Guy Plomteux
Most antidepressants are metabolized by cytochrome P450 (CYP) 2D6, and it is well known that there may be significant interindividual variation in the capacity to metabolize xenobiotics. About 7 to 10% of whites are poor metabolisers (PM), and, on the contrary, about 5% are ultrarapid metabolizers (UM), inducing very different rates in the transformation of antidepressants extensively metabolized by CYP 2D6. CYP 2D6 polymorphism can be a potential risk factor for the development of side effects or a reason for the poor efficacy of the treatment. Various probe drugs may be used for phenotyping CYP 2D6, but genotyping is now available using leukocyte DNA and is independent of concomitant drug use. In this study, we used PCR-based methods for the identification of CYP 2D6 genotypes in 49 patients receiving standard doses of fluoxetine or paroxetine and found that plasma concentration of the antidepressant drugs was significantly correlated with genetic status. In one patient who displayed CYP 2D6 gene duplication (UM), paroxetine plasma concentration was extremely low. In PM fluoxetine-treated patients, drug plasma concentration was significantly higher than that seen in extensive metabolizers.

1 May 2003 in Occupational and Environmental Medicine
Verified
Journal Article
Open access
PDF file
CCC Charlier
C Charlier
AAA Albert
A Albert
PHP Herman
P Herman
EHE Hamoir
E Hamoir
UGU Gaspard
U Gaspard
GPG Plomteux
G Plomteux
Background:Controversy still exists about the breast carcinogenic properties in humans of environmental xenoestrogens (organochlorines), justifying new investigations.Aims:To compare the blood levels of total dichlorodiphenyltrichloroethane (DDT) and hexachlorobenzene (HCB) in samples collected at the time of breast cancer discovery, in order to avoid the potential consequences of body weight change (after chemotherapy or radiotherapy) on the pesticide residue levels.Methods:Blood levels of HCB and total DDT (we calculated total DDT concentrations by adding all DDT and DDE isomers) were compared in 159 women with breast cancer and 250 presumably healthy controls. Risk of breast cancer associated with organochlorine concentration was evaluated.Results:Mean levels of total DDT and HCB were significantly higher for breast cancer patients than for controls. No differences in serum levels of total DDT or HCB were found between oestrogen receptor positive and oestrogen receptor negative patients with breast cancer.Conclusions:These results add to the growing evidence that certain persistent pollutants may occur in higher concentrations in blood samples from breast cancer patients than controls.

1 February 2014 in Science of The Total Environment
Verified
Journal Article
Closed access
CPCatherine Pirard
Catherine Pirard
GKGudrun Koppen
Gudrun Koppen
KCKoen De Cremer
Koen De Cremer
IOIlse Van Overmeire
Ilse Van Overmeire
EGEva Govarts
Eva Govarts
CCCorinne Charlier
Corinne Charlier